tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Charles Duncan, 417 are a BUY (90.06%), 42 are a HOLD (9.07%), 4 are a SELL (0.86%).
Analyst Charles Duncan, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 49.02% that have a potential upside of 51.07% achieved within 308 days.
Charles Duncan’s has documented 902 price targets and ratings displayed on 67 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on SLDB, Solid Biosciences LLC at 22-Sep-2025.
Analyst best performing recommendations are on INO (INOVIO PHARMACEUTICALS).
The best stock recommendation documented was for INO (INOVIO PHARMACEUTICALS) at 3/3/2020. The price target of $144 was fulfilled within 3 days with a profit of $54.6 (61.07%) receiving and performance score of 203.58.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 08-Dec-2021
$23
$-0.99 (-4.13%)
$22
17 days ago
(06-Feb-2026)
17/17 (100%)
$-0.56 (-2.38%)
84
Buy Since 26-Jun-2025
$31
$7.01 (29.22%)
$32
20 days ago
(03-Feb-2026)
0/5 (0%)
$6.24 (25.20%)
Buy Since 21-Oct-2025
$36
$12.01 (50.06%)
$33
1 months 17 days ago
(06-Jan-2026)
0/2 (0%)
$9.06 (33.63%)
Buy Since 17-Oct-2023
$40
$16.01 (66.74%)
$39
1 months 17 days ago
(06-Jan-2026)
2/7 (28.57%)
$13.06 (48.48%)
467
Hold Since 03-Nov-2022
$25
$1.01 (4.21%)
2 months 12 days ago
(11-Dec-2025)
18/21 (85.71%)
$-1.68 (-6.30%)
118
Which stock is Charles Duncan is most bullish on?
What Year was the first public recommendation made by Charles Duncan?
